Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course of Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
NCT01300975Phase 2Completed
- Sponsor
- Fundación Nacional de Dermatología
- Start
- Jan 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Pentavalent antimony in cutaneous leishmaniasis (CL), sponsored by Fundación Nacional de Dermatología. Started Jan 2011; status: completed.
02
Drugs
Pentavalent antimony
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01300975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01300975.